BMO Capital Markets Issues Pessimistic Forecast for NFI Group (TSE:NFI) Stock Price
NFI Group (TSE:NFI – Get Free Report) had its price objective reduced by research analysts at BMO Capital Markets from ...
ETF Daily News4d
BMO Capital Markets Issues Positive Forecast for Protagonist Therapeutics (NASDAQ:PTGX) Stock Price
BMO Capital Markets’ price target suggests a potential upside of 24.89% from the stock’s current price. A number of other brokerages have also issued reports on PTGX.
Yahoo Finance4d
BMO Capital Initiates Coverage on Dyne Therapeutics With Outperform Rating
BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...
Lack of follow-through in post-CPI Treasury rally shows traders focused on tariff fears: strategist
A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...
Okta price target raised to $130 from $105 at BMO Capital
BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...